EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allosteric modulation of the solute carrier transporter SLC39A8 potentiates manganese and cadmium uptake

Kelly L Damm-Ganamet, Clara Moon, Alan D Wickenden, Mark Tichenor, Yunhui Ge, Eduardo V Mercado-Marin, Brian Chiou, Ayla Manughian-Peter, Taraneh Mirzadegan, Jennifer D Venable, Ramnik J Xavier, Jennifer E Towne und 2 weitere

Journal of Clinical Investigation · 03.11.2025 · 135 (21)

DOI: 10.1172/jci191096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.11.2025. Verfasst von Kelly L Damm-Ganamet und 13 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics Discovery and. Hauptthemen laut MEDLINE: Cation Transport Proteins, Manganese, Cadmium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solute carrier (SLC) transporters govern the selective transport of diverse molecules across cell membranes, controlling fundamental metabolic and cellular processes. Despite genetic evidence implicating SLC transporters in a variety of human diseases, this family of proteins represents an underexplored target class for therapeutic drug discovery. Here, we discovered a selective potentiator of SLC39A8, a metal transporter associated with inflammatory bowel disease, schizophrenia, and cardiovascular and metabolic disorders. We conducted a drug repurposing screen, identifying efavirenz as a potentiator of manganese and cadmium uptake by SLC39A8 and subsequently generated structure-activity relationships to guide design of analogs. Computational pocket identification methodology and molecular dynamic simulations revealed a ligandable, cryptic pocket that, together with functional mutagenesis, indicated direct target engagement and allosteric modulation. Our findings demonstrate how the combination of experimental data and computational tools represents a powerful synergy that can enhance scientific outcomes. This integrated approach allowed for iterative feedback where insights from experiments informed the model refinements and computational predictions guided future experimental designs. Furthermore, our data established that SLC39A8 transporter activity can be increased pharmacologically, potentially opening avenues for SLC transporter drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cation Transport ProteinsManganeseCadmiumHumansAllosteric RegulationMolecular Dynamics SimulationHEK293 Cells

Stichwörter der Autor:innen

Genetic diseasesGeneticsInflammatory bowel diseaseTherapeuticsTransport

Substanzen

Cation Transport ProteinsManganeseSLC39A8 protein, humanCadmium

Autor:innen und Institutionen

  • Therapeutics Discovery and.
  • Discovery Immunology, Johnson & Johnson, San Diego, California, USA.
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Discovery Immunology, Johnson & Johnson, Spring House, Pennsylvania, USA.

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • Leona M. and Harry B. Helmsley Charitable Trust

Zitieren

APA

Damm-Ganamet, K. L., Moon, C., Wickenden, A. D., Tichenor, M., Ge, Y., Mercado-Marin, E. V., Chiou, B., Manughian-Peter, A., Mirzadegan, T., Venable, J. D., Xavier, R. J., Towne, J. E., Graham, D. B., & Perrigoue, J. (2025). Allosteric modulation of the solute carrier transporter SLC39A8 potentiates manganese and cadmium uptake. Journal of Clinical Investigation, 135(21). https://doi.org/10.1172/jci191096

Vancouver

Damm-Ganamet KL, Moon C, Wickenden AD, Tichenor M, Ge Y, Mercado-Marin EV, et al. Allosteric modulation of the solute carrier transporter SLC39A8 potentiates manganese and cadmium uptake. Journal of Clinical Investigation. 2025;135(21). doi:10.1172/jci191096

BibTeX
@article{DammGanamet2025,
  author = {Damm-Ganamet, Kelly L and Moon, Clara and Wickenden, Alan D and Tichenor, Mark and Ge, Yunhui and Mercado-Marin, Eduardo V and Chiou, Brian and Manughian-Peter, Ayla and Mirzadegan, Taraneh and Venable, Jennifer D and Xavier, Ramnik J and Towne, Jennifer E and Graham, Daniel B and Perrigoue, Jacqueline},
  title = {Allosteric modulation of the solute carrier transporter SLC39A8 potentiates manganese and cadmium uptake},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {21},
  doi = {10.1172/jci191096}
}
Kostenlos starten →